Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.18038 | 68 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.44007 | 71 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.40851 | 70 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.23361 | 76 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.73721 | 73 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.35392 | 70 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.68369 | 73 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.93158 | 75 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.72951 | 73 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.6248 | 72 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.81447 | 74 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.79199 | 73 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.69 | 73 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.67468 | 73 |